100
Participants
Start Date
May 13, 2024
Primary Completion Date
May 13, 2025
Study Completion Date
May 13, 2026
Tranexamic acid
Experimental group will receive TXA intraoperatively (15mg/kg IV, once at beginning of case then re dose at 4hrs if operation goes longer) at the time of their surgery.
Placebo
Control group will receive same volume equivalent of saline intravenously at the time of their surgery.
RECRUITING
University of Virginia Medical Center, Charlottesville
University of Virginia
OTHER